1
|
Eser-Karlidag G, Chacon-Cruz E, Cag Y, Martinez-Orozco JA, Gudino-Solorio H, Cruz-Flores RA, Gonzalez-Rodriguez A, Martinez-Nieves D, Gomez-Zepeda M, Calderon-Suarez A, Çaşkurlu H, Cascio A, Fernandez R, Gonzales GM, Palma P, Popescu CP, Stebel R, Lakatos B, Nagy E, Lanzafame M, El-Kholy A, Tuncer B, Christova I, Krumova S, Barbosa AN, Escalera-Antezana JP, Castillo-Quino R, Gonzales-Flores CE, Moreira-Flores M, Batallanos-Huarachi MF, Gomez-Davila C, Baljic R, Vieceli T, Ariyo OE, Llobell MC, Gideon OO, Osborne A, Elbahr U, Bossi P, Tammaro A, Rodriguez-Morales AJ, Erdem H. Features of Mpox infection: The analysis of the data submitted to the ID-IRI network. New Microbes New Infect 2023; 53:101154. [PMID: 37260588 PMCID: PMC10227417 DOI: 10.1016/j.nmni.2023.101154] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2023] [Revised: 05/10/2023] [Accepted: 05/12/2023] [Indexed: 06/02/2023] Open
Abstract
Background Mpox is a rare zoonotic disease caused by the Mpox virus. On May 21, 2022, WHO announced the emergence of confirmed Mpox cases in countries outside the endemic areas in Central and West Africa. Methods This multicentre study was performed through the Infectious Diseases International Research Initiative network. Nineteen collaborating centres in 16 countries participated in the study. Consecutive cases with positive Mpoxv-DNA results by the polymerase chain reaction test were included in the study. Results The mean age of 647 patients included in the study was 34.5.98.6% of cases were males, 95.3% were homosexual-bisexual, and 92.2% had a history of sexual contact. History of smallpox vaccination was present in 3.4% of cases. The median incubation period was 7.0 days. The most common symptoms and signs were rashes in 99.5%, lymphadenopathy in 65.1%, and fever in 54.9%. HIV infection was present in 93.8% of cases, and 17.8% were followed up in the hospital for further treatment. In the two weeks before the rash, prodromal symptoms occurred in 52.8% of cases. The incubation period was 3.5 days shorter in HIV-infected Mpox cases with CD4 count <200/μL, we disclosed the presence of lymphadenopathy, a characteristic finding for Mpox, accompanied the disease to a lesser extent in cases with smallpox vaccination. Conclusions Mpox disseminates globally, not just in the endemic areas. Knowledge of clinical features, disease transmission kinetics, and rapid and effective implementation of public health measures are paramount, as reflected by our findings in this study.
Collapse
Affiliation(s)
- Gulden Eser-Karlidag
- Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences Fethi Sekin City Hospital, Elazig, Turkey
| | - Enrique Chacon-Cruz
- Clinica Especializada “CONDESA” Mexico City, Mexico & Research and Advisory, Houston, TX, USA
| | - Yasemin Cag
- Department of Infectious Diseases and Clinical Microbiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey
| | | | | | | | | | | | | | | | - Hülya Çaşkurlu
- Department of Infectious Diseases and Clinical Microbiology, Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkey
| | - Antonio Cascio
- Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties - Infectious Disease Unit, Policlinico ‘P. Giaccone’, University of Palermo, Palermo, Italy
| | - Ricardo Fernandez
- Department of Pulmonary and Critical Care, San Juan City Hospital, San Juan, PR, USA
| | - Greisha M. Gonzales
- Department of Pulmonary and Critical Care, San Juan City Hospital, San Juan, PR, USA
| | - Pedro Palma
- Infectious Diseases Unit, Centro Hospitalar Tamega e Sousa, Penafiel, Portugal
| | - Corneliu Petru Popescu
- Dr.Victor Babes Clinical Hospital of Infectious and Tropical Diseases, Bucharest, Romania
| | - Roman Stebel
- Department of Infectious Diseases, University Hospital Brno and Faculty of Medicine, Masaryk University, Czech Republic
| | - Botond Lakatos
- National Institute of Hematology and Infectious Diseases, Budapest, Hungary
| | - Eva Nagy
- National Institute of Hematology and Infectious Diseases, Budapest, Hungary
| | | | - Amani El-Kholy
- Department of Clinical Pathology, Faculty of Medicine, Cairo University, Egypt
| | - Buse Tuncer
- Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences Fethi Sekin City Hospital, Elazig, Turkey
| | - Iva Christova
- National Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria
| | - Stefka Krumova
- National Centre of Infectious and Parasitic Diseases, Sofia, Bulgaria
| | | | | | | | | | | | | | | | | | - Tarsila Vieceli
- Department of Infectious Diseases, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
| | | | | | | | - Augustus Osborne
- Department of Biological Sciences, Njala University, Sierra Leone
| | - Umran Elbahr
- Department of Infectious Diseases, Bahrain Oncology Center, King Hamad University Hospital, Busaiteen, Bahrain
| | | | | | - Alfonso J. Rodriguez-Morales
- Grupo de Investigación Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de Las Americas-Institución Universitaria Visión de Las Américas, Pereira, Risaralda, Colombia
- Master of Clinical Epidemiology and Biostatistics, Universidad Científica Del Sur, Lima, Peru
- Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, P.O. Box 36, Lebanon
| | | |
Collapse
|